National Prostate Cancer Audit (NPCA)

The National Prostate Cancer Audit (NPCA) is a national clinical audit commissioned by the Healthcare Quality Improvement Partnership (HQIP) in response to the need for better information about the quality of services and care provided to patients with prostate cancer in England and Wales. The NPCA is undertaken at the Clinical Effectiveness Unit (CEU) of the Royal College of Surgeons and from 1 April 2013 to 30 June 2023 worked in partnership with the National Disease Registration Service (NDRS) and the Wales Cancer Network (WCN), and used the routine data collected by these national bodies.

The audit joined the National Cancer Audit Collaborating Centre (NATCAN)  on 1 July 2023, which brings together existing cancer audits (gastro-oesphageal and bowel) with newly commissioned audits in kidney, ovarian, pancreatic, primary and metastatic breast and non-Hodgkin lymphoma.

The aim of the NPCA is to assess the process of care and its outcomes in men diagnosed with prostate cancer in England and Wales.

The NPCA determines whether a persons prostate cancer care is consistent with current recommended practice. It also provides information to support healthcare providers, commissioners, regulators, patient groups and patients to improve prostate cancer diagnosis and treatment.

To find out more and view the most recent NPCA reports and dashboards visit the NPCA website

The NCPA also publishes regular newsletters which can be viewed via the news page on the NCPA website. 

To view the latest peer-reviewed publications that show some of the latest findings using the NPCA data visit the publications page on the NCPA website.